Erasca (ERAS) EBT Growth (1y) (2021 - 2026)
Erasca (ERAS) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-79.57% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-313.33% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Erasca |
4.16 Bn |
3.92 Bn |
- |
-492.46% |
| Date | Value |
|---|
| Mar 31, 2026 |
-492.46% |
| Dec 31, 2025 |
4.57% |
| Sep 30, 2025 |
2.54% |
| Jun 30, 2025 |
46.40% |
| Mar 31, 2025 |
11.57% |
| Dec 31, 2024 |
-2.45% |
| Sep 30, 2024 |
-3.33% |
| Jun 30, 2024 |
-98.86% |
| Mar 31, 2024 |
-5.48% |
| Dec 31, 2023 |
78.04% |
| Sep 30, 2023 |
14.45% |
| Jun 30, 2023 |
10.75% |
| Mar 31, 2023 |
8.94% |
| Dec 31, 2022 |
-336.74% |
| Sep 30, 2022 |
22.97% |
| Jun 30, 2022 |
-26.21% |
| Mar 31, 2022 |
-85.71% |
| Dec 31, 2021 |
53.73% |
| Sep 30, 2021 |
-312.69% |
| Jun 30, 2021 |
-289.32% |
